Pathways for aberrant angiogenesis in pancreatic cancer

被引：129

作者：

M Korc

机构：

[1] Div. of Endocrinol. Diabetes/Metab., Department of Medicine, University of California, Irvine

来源：

关键词：

Vascular Endothelial Growth Factor; Pancreatic Cancer; Hepatocyte Growth Factor; Pancreatic Cancer Cell; Pancreatic Cancer Cell Line;

D O I：

10.1186/1476-4598-2-8

中图分类号：

学科分类号：

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. Although the specific mechanisms that dictate its biological aggressiveness are not clearly established, it is characterized by a variety of molecular alterations as well as by the overexpression of mitogenic and angiogenic growth factors and their receptors. PDACs also express high levels of vascular endothelial growth factor (VEGF). Recent studies indicate that suppression of VEGF expression attenuates pancreatic cancer cell tumorigenicity in a nude mouse model, and that VEGF can exert direct mitogenic effects on some pancreatic cancer cells. These findings suggest that cancer cell derived VEGF promotes pancreatic cancer growth in vivo via a paracrine angiogenic pathway and an autocrine mitogenic pathway, and provide novel opportunities for therapeutic intervention in this deadly disease. © 2003 Korc; licensee BioMed Central Ltd.

引用

页数：8

共 145 条

[1]

Warshaw A.L., Fernandez-del Castillo C., Pancreatic carcinoma, N. Engl. J. Med., 326, 7, pp. 455-465, (1992)

[2]

Parker S.L., Cancer statistics, 1997, CA Cancer J. Clin., 47, 1, pp. 5-27, (1997)

[3]

Bramhall S.R., Neoptolemos J.P., Adjuvant chemotherapy in pancreatic cancer, Int. J. Pancreatol., 21, 1, pp. 59-63, (1997)

[4]

Abrams R.A., Role of radiation therapy in the management of the patient with pancreatic cancer, Oncology (Huntingt), 10, 9 SUPPL., pp. 13-17, (1996)

[5]

Kuvshinoff B.W., Bryer M.P., Treatment of resectable and locally advanced pancreatic cancer, Cancer Control, 7, 5, pp. 428-436, (2000)

[6]

Korc M., Role of growth factors in pancreatic cancer, Surg. Oncol. Clin. N. Am., 7, 1, pp. 25-41, (1998)

[7]

Kern S.E., Molecular genetic alterations in ductal pancreatic adenocarcinomas, Med. Clin. North Am., 84, 3, pp. 691-695, (2000)

[8]

Korc M., Meltzer P., Trent J., Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer, Proc. Natl. Acad. Sci. U. S. A., 83, 14, pp. 5141-5144, (1986)

[9]

Smith J.J., Derynck R., Korc M., Production of transforming growth factor alpha in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle, Proc. Natl. Acad. Sci. U. S. A., 84, 21, pp. 7567-7570, (1987)

[10]

Ebert M., Induction and expression of amphiregulin in human pancreatic cancer, Cancer Res., 54, 15, pp. 3959-3962, (1994)

← 1 2 3 4 5 6 7 8 9 10 →